Key result
At 3T, contrast-enhanced steady-state free precession CMR accurately quantified at-risk myocardium in reperfused acute myocardial infarction patients, demonstrating strong agreement with SPECT (R2 = 0.86, p < 0.001).
Why the study?
CE-SSFP CMR at 1.5T can quantify the area-at-risk in AMI, but its capacity to assess area-at-risk at 3T has not been investigated.
Does CE-SSFP CMR at 3T accurately quantify area-at-risk compared to T2-STIR and SPECT in reperfused acute myocardial infarction patients?
Observational (n=60)
Blinded image analysis
No
Does CE-SSFP CMR at 3T accurately quantify area-at-risk compared to T2-STIR and SPECT in reperfused acute myocardial infarction patients?
At 3T, both CE-SSFP and T2-STIR CMR can accurately quantify the at-risk myocardium in reperfused AMI patients, showing good agreement with SPECT validation.
May support CMR for at-risk myocardium quantification at 3T; leaves open prospective validation versus SPECT.
Contrast-enhanced (CE) steady-state free precession (SSFP) CMR at 1.5T has been shown to be a valuable alternative to T2-based methods for the detection and quantifications of area-at-risk (AAR) in acute myocardial infarction (AMI) patients. However, CE-SSFP’s capacity for assessment of AAR at 3T has not been investigated. We examined the clinical utility of CE-SSFP and T2-STIR for the retrospective assessment of AAR at 3T with single-photon-emission-computed tomography (SPECT) validation. A total of 60 AMI patients (ST-elevation AMI, n = 44; non-ST-elevation AMI, n = 16) were recruited into the CMR study between 3 and 7 days post revascularization. All patients underwent T2-STIR, CE-bSSFP and late-gadolinium-enhancement CMR. For validation, SPECT images were acquired in a subgroup of patients (n = 30). In 53 of 60 patients (88 %), T2-STIR was of diagnostic quality compared with 54 of 60 (90 %) with CE-SSFP. In a head-to-head per-slice comparison (n = 365), there was no difference in AAR quantified using T2-STIR and CE-SSFP (R 2 = 0.92, p < 0.001; bias:-0.4 ± 0.8 cm 2 , p = 0.46). On a per-patient basis, there was good agreement between CE-SSFP (n = 29) and SPECT (R 2 = 0.86, p < 0.001; bias: − 1.3 ± 7.8 %LV, p = 0.39) for AAR determination. T2-STIR also showed good agreement with SPECT for AAR measurement (R 2 = 0.81, p < 0.001, bias: 0.5 ± 11.1 %LV, p = 0.81). There was also a strong agreement between CE-SSFP and T2-STIR with respect to the assessment of AAR on per-patient analysis (R 2 = 0.84, p < 0.001, bias: − 2.1 ± 10.1 %LV, p = 0.31). At 3T, both CE-SSFP and T2-STIR can retrospectively quantify the at-risk myocardium with high accuracy.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) conducted an observational in Acute myocardial infarction (n=60). Contrast-enhanced steady-state free precession (CE-SSFP) CMR at 3T vs. SPECT and T2-STIR CMR was evaluated on Area-at-risk (AAR) quantification agreement with SPECT (R2 = 0.86, bias: -1.3 ± 7.8 %LV, p=<0.001). At 3T, contrast-enhanced steady-state free precession CMR accurately quantified at-risk myocardium in reperfused acute myocardial infarction patients, demonstrating strong agreement with SPECT (R2 = 0.86, p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: